Cognos Announces U.S. Patent Award for Cerebral Microdialysi

INGLEWOOD, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Cognos Therapeutics, Inc. (“Cognos” or the “Company”), a medical technology company focused on developing implantable smart pump technology, today announced its U.S.

Related Keywords

United States , Cayman Islands , Japan , China , Australia , Mexico , Canada , Henry Monzon , Ka Seng Thomas , Frank Adell , Vivian Cervantes , Cogno Sinnais , Nocturne Acquisition Corp , Us Patent Office , Cognos , Cognos Therapeutics Inc , Nocturne Acquisition Corporation , Gilmartin Group , Chief Executive Officer , Cognos Therapeutics , Smart Drug Delivery System , Chief Financial , Business Combination , Private Securities Litigation Reform Act , Information About , Registration Statement , Securities Act , Region ,